China Healthwise Holdings (HKSE:00348) COGS-to-Revenue : 0.59 (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is China Healthwise Holdings COGS-to-Revenue?

China Healthwise Holdings's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$38.9 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$65.5 Mil.

China Healthwise Holdings's COGS to Revenue for the six months ended in Dec. 2023 was 0.59.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. China Healthwise Holdings's Gross Margin % for the six months ended in Dec. 2023 was 40.68%.

China Healthwise Holdings COGS-to-Revenue Historical Data

The historical data trend for China Healthwise Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Healthwise Holdings COGS-to-Revenue Chart

China Healthwise Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.64

0.56

0.46

0.63

0.59

China Healthwise Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.51	0.65	0.59	0.58	0.59

China Healthwise Holdings COGS-to-Revenue Calculation

China Healthwise Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	86.023	/	146.317
	=	0.59

China Healthwise Holdings's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	38.85	/	65.491
	=	0.59

China Healthwise Holdings (HKSE:00348) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

China Healthwise Holdings's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	38.85 / 65.491
	=	40.68 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

China Healthwise Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of China Healthwise Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

China Healthwise Holdings (HKSE:00348) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Healthwise Holdings Ltd (HKSE:00348) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

168-200 Connaught Road Central, Unit 1209, Shun Tak Centre, West Tower, Hong Kong, HKG

Website

http://www.healthwisehk.com/en

China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which include pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.

Executives

Eternity Investment Limited	2201 Interest of corporation controlled by you
Heng Tai Consumables Group Limited	2201 Interest of corporation controlled by you
Heng Tai Finance Limited	2101 Beneficial owner
Lei Hong Wai	2101 Beneficial owner

China Healthwise Holdings (HKSE:00348) Headlines

No Headlines